PRAX Q1 2026 Earnings EPS Beat Amid Continued RD Focus CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss MLSS Q1 2026 Earnings NarrowerThanExpected Loss Per Share Viking Holdings VIK Q1 2026 Earnings NarrowerThanExpected Loss Amid Solid Booking Momentum Xylem Q1 2026 Earnings EPS Slightly Above Estimates Amid Operational Strength Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism